In this presentation, Dr. Andrew Saxon reviews the use of pharmacologic agents for the treatment of stimulant use disorder. He discusses the central role of dopamine in stimulant use, as well as the course, assessment, and diagnosis of stimulant use disorder. He likewise reviews the evidence for the use of various psychopharmacologic agents for these disorders, such as antidepressants and naltrexone for methamphetamine use disorder and topiramate and methylphenidate for cocaine use disorder.
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/experimental-pharmacotherapies-for-stimulant-use-disorder-2622?utm_source=PARS+ACCME&utm_medium=PARS+ACCME&utm_campaign=PARS+ACCME
- Start Date: 2022-04-01 05:00:00
- End Date: 2022-04-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest